-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, at the 4th China International Import Expo in 2021, Hanhui Pharmaceutical and Huiyi World Internet Medical Platform signed a strategic cooperation agreement
.
According to the agreement, the two parties will integrate resources and jointly explore the digital full-course management model for chronic diseases such as digestion and hyperlipidemia, and create a high-quality closed loop of out-of-hospital health management for patients with chronic diseases
.
It is worth noting that on the same day, Huiyi Tianxia and Leo Pharmaceutical (Shanghai) Co.
, Ltd.
further deepened the existing strategic partnership
.
On the same day, at the China International Import Expo, the two parties also formally held a cooperation launch ceremony to jointly promote the construction of an Internet specialist hospital for dermatology
.
It is understood that in recent years, with the rise of emerging technologies such as big data and AI, the Internet platform has gradually become an emerging force in the transformation and upgrading of China's medical system
.
At the same time, its integration and innovation with the pharmaceutical industry has gradually become a new trend in the development of the industry
.
At present, in addition to the above companies, many companies have been cooperating with Internet platforms to accelerate digital transformation since the beginning of this year
.
For example, in September, Novartis Pharmaceuticals reached a strategic cooperation with Ark Jianke Group
.
The two parties announced that they will carry out in-depth cooperation in drug services, disease management, and doctor-patient education around the "Quan Xin Quan Yi" project, and jointly explore the digital service model of "Internet + Heart Failure and Chronic Disease Management" to provide patients with a multi-faceted approach.
, Refined health management services
.
In June, Shanghai Youlin Pharmaceutical Technology Co.
, Ltd.
announced the completion of an A+ round of financing of over 100 million yuan
.
According to the announcement, after this round of financing, the funds obtained by Clinical Medicine will be used to accelerate the development and deployment of digital clinical trial systems and the expansion of professional clinical service teams
.
In April, Kelun Pharmaceutical also signed a cooperation agreement with Dipu Technology in the field of digital intelligence in medicine.
The two parties will focus on lean management to help Kelun build a multi-faceted digital and intelligent medicine platform. .
In addition, in March, BeiGene “joined hands” with 1yao.
com and made it clear that it would cooperate around “Internet + medical health” to jointly build an Internet hospital cancer disease management platform, and create doctor-patient communication and disease course for cancer patients in China.
The whole-process digital "medicine + medicine" service model including management and online and offline DTP delivery of medicines to the door
.
The industry believes that at present, domestic and foreign pharmaceutical companies are using digital and Internet platforms to accelerate transformation and the ability to transform pharmaceutical scientific and technological achievements
.
In this context, the industry predicts that with the continuous progress and development of technology and the continuous introduction of the "Internet +" policy, the pharmaceutical industry will usher in a great opportunity for transformation and upgrading
.
Professionalism, depth, openness, and cooperation models will be the new development trend of the pharmaceutical industry, and the Internet platform and digital technology will become its strong driving force
.
However, it should be noted that the transformation through Internet + is not a simple matter.
It is necessary to use a systematic and scientific method to formulate a digital transformation strategy based on the company's own development stage
.
Only in this way can we ensure the actual implementation of the transformation and upgrading
.
.
According to the agreement, the two parties will integrate resources and jointly explore the digital full-course management model for chronic diseases such as digestion and hyperlipidemia, and create a high-quality closed loop of out-of-hospital health management for patients with chronic diseases
.
It is worth noting that on the same day, Huiyi Tianxia and Leo Pharmaceutical (Shanghai) Co.
, Ltd.
further deepened the existing strategic partnership
.
On the same day, at the China International Import Expo, the two parties also formally held a cooperation launch ceremony to jointly promote the construction of an Internet specialist hospital for dermatology
.
It is understood that in recent years, with the rise of emerging technologies such as big data and AI, the Internet platform has gradually become an emerging force in the transformation and upgrading of China's medical system
.
At the same time, its integration and innovation with the pharmaceutical industry has gradually become a new trend in the development of the industry
.
At present, in addition to the above companies, many companies have been cooperating with Internet platforms to accelerate digital transformation since the beginning of this year
.
For example, in September, Novartis Pharmaceuticals reached a strategic cooperation with Ark Jianke Group
.
The two parties announced that they will carry out in-depth cooperation in drug services, disease management, and doctor-patient education around the "Quan Xin Quan Yi" project, and jointly explore the digital service model of "Internet + Heart Failure and Chronic Disease Management" to provide patients with a multi-faceted approach.
, Refined health management services
.
In June, Shanghai Youlin Pharmaceutical Technology Co.
, Ltd.
announced the completion of an A+ round of financing of over 100 million yuan
.
According to the announcement, after this round of financing, the funds obtained by Clinical Medicine will be used to accelerate the development and deployment of digital clinical trial systems and the expansion of professional clinical service teams
.
In April, Kelun Pharmaceutical also signed a cooperation agreement with Dipu Technology in the field of digital intelligence in medicine.
The two parties will focus on lean management to help Kelun build a multi-faceted digital and intelligent medicine platform. .
In addition, in March, BeiGene “joined hands” with 1yao.
com and made it clear that it would cooperate around “Internet + medical health” to jointly build an Internet hospital cancer disease management platform, and create doctor-patient communication and disease course for cancer patients in China.
The whole-process digital "medicine + medicine" service model including management and online and offline DTP delivery of medicines to the door
.
The industry believes that at present, domestic and foreign pharmaceutical companies are using digital and Internet platforms to accelerate transformation and the ability to transform pharmaceutical scientific and technological achievements
.
In this context, the industry predicts that with the continuous progress and development of technology and the continuous introduction of the "Internet +" policy, the pharmaceutical industry will usher in a great opportunity for transformation and upgrading
.
Professionalism, depth, openness, and cooperation models will be the new development trend of the pharmaceutical industry, and the Internet platform and digital technology will become its strong driving force
.
However, it should be noted that the transformation through Internet + is not a simple matter.
It is necessary to use a systematic and scientific method to formulate a digital transformation strategy based on the company's own development stage
.
Only in this way can we ensure the actual implementation of the transformation and upgrading
.
